Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a research report report published on Friday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Price Performance

Shares of NASDAQ:AVGR opened at $0.47 on Friday. The business has a fifty day moving average price of $0.67 and a 200-day moving average price of $0.87. The company has a market capitalization of $1.57 million, a PE ratio of -0.04 and a beta of 1.09. Avinger has a 1-year low of $0.36 and a 1-year high of $5.45.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.